Identification of multiple constituents in the traditional Chinese medicine formula GuiZhiFuLing-Wan by HPLC–DAD–MS/MS
- 1 February 2009
- journal article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 49 (2), 267-275
- https://doi.org/10.1016/j.jpba.2008.11.012
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Protective effects of keishibukuryogan on the kidney of spontaneously diabetic WBN/Kob ratsJournal of Ethnopharmacology, 2006
- Therapeutic wisdom in traditional Chinese medicine: a perspective from modern scienceTrends in Pharmacological Sciences, 2005
- Oren-gedoku-to and Keishi-bukuryo-gan-ryo Inhibit the Progression of Atherosclerosis in Diet-Induced Hypercholesterolemic RabbitsBiological & Pharmaceutical Bulletin, 2005
- Comparing the Effects of Estrogen and an Herbal Medicine on Peripheral Blood Flow in Post-menopausal Women with Hot Flashes: Hormone Replacement Therapy and Gui-Zhi-Fu-Ling-Wan, a Kampo MedicineThe American Journal of Chinese Medicine, 2005
- Protective effect of Keishi-bukuryo-gan and its constituent medicinal plants against nitric oxide donor-induced neuronal death in cultured cerebellar granule cellsPhytomedicine, 2004
- The antiplatelet activity of Geiji-Bokryung-Hwan, Korean traditional formulation, is mediated through inhibition of phospholipase C and inhibition of TxB2 synthetase activityInternational Immunopharmacology, 2003
- A water-extract of the Korean traditional formulation Geiji–Bokryung–Hwan reduces atherosclerosis and hypercholesteremia in cholesterol-fed rabbitsInternational Immunopharmacology, 2003
- The New Face of Traditional Chinese MedicineScience, 2003
- Current status and future direction of Chinese herbal medicineTrends in Pharmacological Sciences, 2002
- Monoterpene glycosides from Paeonia suffruticosaPhytochemistry, 1996